Market Diversification Alternative Biomedical Solutions serves a wide range of mature and emerging markets including toxicology, pain management, drug rehabilitation, criminal justice, forensic, environmental, and cannabis industries, creating opportunities to tailor solutions and expand product offerings across these sectors.

Growth Potential With a revenue range of 10 to 25 million dollars and a dedicated team of up to 200 employees, ABS is positioned as a mid-sized company that is likely seeking scalable lab and technology solutions to support its expanding client base and service capabilities.

Recent Leadership Updates The appointment of a new CEO and key business development hires in early 2022 indicate active strategic growth and market outreach initiatives, suggesting opportunities to introduce advanced testing technologies and consulting services aligned with their leadership's strategic vision.

Technology Adoption ABS utilizes a modern tech stack including analytics and web tools like Google Analytics, PHP, and Unbounce, highlighting an openness to digital solutions that can streamline operations, improve customer engagement, and optimize marketing efforts—potential areas for upselling integrated tech services.

Client Support and Innovation Operating a state-of-the-art reference laboratory and emphasizing unbiased, OEM-neutral solutions offer avenues for sales of specialized laboratory equipment, quality assurance tools, and custom analytical services suited to their diverse industry needs.